Three Rivers Pharmaceuticals

About:

Three Rivers Pharmaceuticals develops, manufactures, and markets generic pharmaceutical drug products.

Description:

Three Rivers Pharmaceuticals, LLC develops, manufactures, and markets generic pharmaceutical drug products in the United States and internationally. It offers prescription drugs in the therapeutic categories of antiviral and antifungal agents. The company’s products include AMPHOTEC for the treatment of invasive aspergillosis, a systemic fungal infection; and INFERGEN, RIBASPHERE tablets, RIBASPHERE capsules, and RibaPak tablets for the treatment of hepatitis C. It also markets Topotecan Hydrochloride for injection. Three Rivers Pharmaceuticals, LLC was founded in 2000 and is based in Warrendale, Pennsylvania. As of October 25, 2010, Three Rivers Pharmaceuticals, LLC operates as a subsidiary of Kadmon Pharmaceuticals LLC.

Total Funding Amount:

$6.56M

Headquarters Location:

Warrendale, Pennsylvania, United States

Founded Date:

2000-01-01

Founders:

Paul F. Fagan

Number of Employees:

101-250

Last Funding Date:

2009-04-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai